The Outcome of Prolanis (Program Pengelolaan Penyakit Kronis/Chronic Disease Management Program) in Jatirejo Primary Health Care

Background: Indonesia is one of the fastest-aging countries. The increased elderly population carries the burden of chronic diseases such as hypertension and diabetes mellitus, along with their complications. The reinforcement of lifestyle changes has been promoted in primary healthcare through the Prolanis program to reduce these diseases’ burden, though its effectivity is unknown. Objective: To evaluate the outcome of the Prolanis program in Jatirejo Primary Healthcare. Methods: In this study, 61 patients were recruited from November 2021 – April 2022. Data were obtained from medical records as pre- and post-follow-up in 6 months period. Data pre- and post-follow-up were analyzed using the Wilcoxon and dependent T-test. Results: There were 64.52% patients with systolic hypertension. The median data of pre- and post- follow up showed that: HbA1C was 5.9% (range 3 – 13) and 6.3% (range 5 – 11) (p 0,959); BUN was 15,3 mg/dL (range 10 – 32) and 14,8 mg/dL (range 13 – 25) (p 0,638); serum creatinine was 0,8 mg/dL (range 0,4 – 3,1) and 1,2 mg/dL (range 0,7 – 2,6) (p 0,026); total cholesterol was 183 (range, 123 – 300) and 219 (range 179 – 231) (p 0,008); triglycerides was 133 (range 82 – 326) and 159 (range 135 – 394) (p 0,416); HDL was 40,65 SD ± 2 and 41 SD ± 2,3 (p 0,206); LDL was 117,5 SD ± 35 and 139,7 SD ± 20 (p 0,886); and urine microalbumin was 53 (range 5 – 200) and 63,5 (range 5 – 200) (p 0,721). Conclusion: Improvement in patients’ outcomes has not been shown after Prolanis program. Further study with larger populations and more variables is needed.